Aethlon Medical, Inc.
Aethlon Medical, Inc. (AEMD) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
aemd · stock forecast · 3 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Hold
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.03
Short-Term Price Prediction
Short-term predictions are paused during the ±3-day earnings window to avoid unreliable signals.
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AEMD · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-11-15 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2022-11-14 | Maxim Group | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Aethlon Medical, Inc. (AEMD) stock. Of the recent 17 rating actions, 0 were upgrades and 2 were downgrades. 3 analysts currently cover AEMD.
Analyst Recommendation Trends
AEMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$126M
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-10.21
EPS Next Year
$-2.21
↓ 78.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast AEMD EPS of $-10.21 for the current fiscal year, based on estimates from 1 analysts. The AEMD revenue forecast is $126M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AEMD stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AEMD price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
Aethlon Medical, Inc. trades on NASDAQ under the ticker AEMD. The AEMD stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.
Frequently asked questions
AEMD forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month AEMD price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $2.03.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.